Q (sonnet): What is the correlation coefficient between EGFR copy number and EGFR mRNA expression in ovarian cancer?

▶ read_guide
{
 "uri": "cbioportal://gene-expression-guide"
}

▶ list_studies
{
 "search": "ovarian"
}

◀ result
# Gene Expression Analysis Guide

This guide covers continuous-value genomic data: gene **expression**, **copy number** values, **methylation**, and related profile types. Mutation/CNA/SV *frequency* analysis lives in `cbioportal://mutation-frequency-guide`.

## Where this data lives

Continuous per-sample-per-gene values are stored in `genetic_alteration_derived`:

| Column | Description |
|---|---|
| `sample_unique_id` | `<study>_<sample_stable_id>` |
| `cancer_study_identifier` | study scope |
| `hugo_gene_symbol` | gene |
| `profile_type` | which assay/normalization (see below) |
| `alteration_value` | the actual value — stored as Nullable(String); cast with `toFloat64OrNull` |

`alteration_value` is a string because the same column hosts many different value scales. The `''` and `'NA'` sentinels mean "missing"; always filter them out and use `toFloat64OrNull(alteration_value) IS NOT NULL` for downstream math.

## Discovering profile types for a study

Different studies expose different profile types depending on what assays were run and how the data was normalized. Always check what a specific study supports before picking one:

```sql
SELECT DISTINCT profile_type
FROM genetic_alteration_derived
WHERE cancer_study_identifier = 'brca_metabric'
ORDER BY profile_type;
```

Common values across the public portal:

| Family | Profile types |
|---|---|
| mRNA expression | `rna_seq_v2_mrna`, `rna_seq_v2_mrna_median_Zscores`, `rna_seq_v2_mrna_median_all_sample_Zscores` (TCGA PanCancer Atlas), `mrna`, `mrna_median_Zscores`, `mrna_seq_v2_rsem`, `mrna_seq_v2_rsem_Zscores`, `mrna_seq_cpm`, `mrna_seq_fpkm`, `mrna_U133`, `mrna_outliers` |
| Copy number (continuous) | `cna`, `linear_CNA`, `log2CNA`, `cna_consensus`, `cna_rae`, `gistic` |
| Methylation | `methylation_hm27`, `methylation_hm450`, `methylation_epic`, `methylation_promoters_rrbs` |
| miRNA | `mirna`, `mirna_median_Zscores` |
| Protein | `protein_quantification`, `protein_level`, `RPPA` |

**Z-score vs raw choice.** When the user asks "is X correlated with Y", either works for Spearman (rank-based) — Pearson would care. Default to the non-Z-score variant if both exist, and call out which one in the response.

## Canonical recipe — Spearman correlation between two genes

```sql
SELECT *
FROM gene_pair_coexpression(
    study        = 'brca_metabric',
    gene_a       = 'TP53',
    gene_b       = 'MYC',
    profile_type = 'mrna'
);
```

Returns one row: `(gene_a, gene_b, profile_type, spearman_correlation, num_samples)`.

- `spearman_correlation` in [−1, 1]; `NULL` when fewer than 3 valid paired samples.
- Mirrors cbioportal-backend's `ClickhouseCoExpressionMapper.getCoExpressions`, simplified to a pair lookup (the backend computes one ref gene vs ALL other genes for the coexpression page; here the agent asks about a specific pair).

### Verified examples

| Study | gene_a | gene_b | profile_type | spearman | n |
|---|---|---|---|---|---|
| `brca_metabric` | TP53 | MYC | `mrna` | 0.118 | 1980 |
|  … (4931 more chars)

◀ result
{"result":[{"cancer_study_identifier":"msk_met_2021","name":"MSK MetTropism (MSK, Cell 2021)","type_of_cancer_id":"mixed","sample_count":25775,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=msk_met_2021"},{"cancer_study_identifier":"ov_tcga","name":"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"hgsoc","sample_count":617,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ov_tcga"},{"cancer_study_identifier":"hgsoc_tcga_gdc","name":"High-Grade Serous Ovarian Cancer (TCGA GDC, 2025)","type_of_cancer_id":"hgsoc","sample_count":604,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=hgsoc_tcga_gdc"},{"cancer_study_identifier":"ov_tcga_pan_can_atlas_2018","name":"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"hgsoc","sample_count":585,"has_guide":true,"url":"https://www.cbioportal.org/study/summary?id=ov_tcga_pan_can_atlas_2018"},{"cancer_study_identifier":"ovary_geomx_gray_foundation_2024","name":"Ovarian Cancer (Gray Foundation, Cancer Discov 2024)","type_of_cancer_id":"ovary","sample_count":567,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ovary_geomx_gray_foundation_2024"},{"cancer_study_identifier":"ov_tcga_pub","name":"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)","type_of_cancer_id":"hgsoc","sample_count":489,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ov_tcga_pub"},{"cancer_study_identifier":"lgsoc_mapk_msk_2022","name":"Low-Grade Serous Ovarian Cancer (MSK, Clin Cancer Res 2022)","type_of_cancer_id":"lgsoc","sample_count":119,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=lgsoc_mapk_msk_2022"},{"cancer_study_identifier":"ovary_cptac_gdc","name":"Ovarian Cancer (CPTAC GDC, 2025)","type_of_cancer_id":"ovary","sample_count":112,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ovary_cptac_gdc"},{"cancer_study_identifier":"msk_spectrum_tme_2022","name":"Ovarian Cancer - MSK SPECTRUM (MSK, Nature 2022)","type_of_cancer_id":"ovary","sample_count":82,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=msk_spectrum_tme_2022"},{"cancer_study_identifier":"hgsoc_msk_2021","name":"High-Grade Serous Ovarian Cancer (MSK, NPJ Genome Med 2021)","type_of_cancer_id":"hgsoc","sample_count":45,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=hgsoc_msk_2021"},{"cancer_study_identifier":"ucec_msk_2024","name":"Endometrial and Ovarian Cancer (MSK, Nature Medicine 2024)","type_of_cancer_id":"mixed","sample_count":33,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ucec_msk_2024"},{"cancer_study_identifier":"ovarian_msk_2025","name":"Serous Ovarian Cancer (MSK, 2025)","type_of_cancer_id":"ovary","sample_count":31,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ovarian_msk_2025"},{"cancer_study_identifier":"mixed_msk_tcga_2021","name":"RAD51B Associated Mixed Cancers (MSK, N … (162 more chars)

▶ clickhouse_run_select_query
{
 "query": "SELECT DISTINCT profile_type FROM genetic_alteration_derived WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018' ORDER BY profile_type"
}

◀ result
{"rows":[{"profile_type":"gistic"},{"profile_type":"log2CNA"},{"profile_type":"protein_quantification"},{"profile_type":"protein_quantification_zscores"},{"profile_type":"rna_seq_v2_mrna"},{"profile_type":"rna_seq_v2_mrna_median_Zscores"},{"profile_type":"rna_seq_v2_mrna_median_all_sample_Zscores"},{"profile_type":"rppa"},{"profile_type":"rppa_Zscores"}]}

▶ clickhouse_run_select_query
{
 "query": "
WITH cna AS (
    SELECT sample_unique_id, toFloat64OrNull(alteration_value) AS v
    FROM genetic_alteration_derived
    WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018'
      AND profile_type = 'log2CNA'
      AND hugo_gene_symbol = 'EGFR'
      AND alteration_value NOT IN ('', 'NA')
      AND toFloat64OrNull(alteration_value) IS NOT NULL
),
expr AS (
    SELECT sample_unique_id, toFloat64OrNull(alteration_value) AS v
    FROM genetic_alteration_derived
    WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018'
      AND profile_type = 'rna_seq_v2_mrna'
      AND hugo_gene_symbol = 'EGFR'
      AND alteration_value NOT IN ('', 'NA')
      AND toFloat64OrNull(alteration_value) IS NOT NULL
)
SELECT
  round(corr(cna.v, log2(expr.v + 1)), 3) AS pearson_r_log2expr,
  round(rankCorr(cna.v, expr.v), 3) AS spearman_rho,
  count() AS num_samples
FROM cna INNER JOIN expr USING (sample_unique_id)
"
}

◀ result
{"rows":[{"pearson_r_log2expr":0.342,"spearman_rho":0.364,"num_samples":295}]}

▶ clickhouse_run_select_query
{
 "query": "
WITH cna AS (
    SELECT sample_unique_id, toFloat64OrNull(alteration_value) AS v
    FROM genetic_alteration_derived
    WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018'
      AND profile_type = 'gistic'
      AND hugo_gene_symbol = 'EGFR'
      AND alteration_value NOT IN ('', 'NA')
      AND toFloat64OrNull(alteration_value) IS NOT NULL
),
expr AS (
    SELECT sample_unique_id, toFloat64OrNull(alteration_value) AS v
    FROM genetic_alteration_derived
    WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018'
      AND profile_type = 'rna_seq_v2_mrna'
      AND hugo_gene_symbol = 'EGFR'
      AND alteration_value NOT IN ('', 'NA')
      AND toFloat64OrNull(alteration_value) IS NOT NULL
)
SELECT
  round(rankCorr(cna.v, expr.v), 3) AS spearman_rho_gistic_vs_expr,
  count() AS num_samples
FROM cna INNER JOIN expr USING (sample_unique_id)
"
}

◀ result
{"rows":[{"spearman_rho_gistic_vs_expr":0.411,"num_samples":295}]}

▶ resolve_and_route
{
 "studyIds": [
  "ov_tcga_pan_can_atlas_2018"
 ]
}

◀ result
{"success":true,"message":"Found 1 study. Use the metadata to call the appropriate navigation tool(s).","data":{"totalCount":1,"studiesWithMetadata":[{"studyId":"ov_tcga_pan_can_atlas_2018","name":"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)","sampleCount":585,"studyViewUrl":"https://www.cbioportal.org/study?id=ov_tcga_pan_can_atlas_2018","metadata":{"clinicalAttributeIds":["AGE","AJCC_PATHOLOGIC_TUMOR_STAGE","AJCC_STAGING_EDITION","ANEUPLOIDY_SCORE","BUFFA_HYPOXIA_SCORE","CANCER_TYPE","CANCER_TYPE_ACRONYM","CANCER_TYPE_DETAILED","DAYS_LAST_FOLLOWUP","DAYS_TO_BIRTH","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DFS_MONTHS","DFS_STATUS","DSS_MONTHS","DSS_STATUS","ETHNICITY","FORM_COMPLETION_DATE","FRACTION_GENOME_ALTERED","GENETIC_ANCESTRY_LABEL","GRADE","HISTORY_NEOADJUVANT_TRTYN","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","INFORMED_CONSENT_VERIFIED","IN_PANCANPATHWAYS_FREEZE","MSI_SCORE_MANTIS","MSI_SENSOR_SCORE","MUTATION_COUNT","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER_PATIENT_ID","PATH_M_STAGE","PATH_N_STAGE","PATH_T_STAGE","PERSON_NEOPLASM_CANCER_STATUS","PFS_MONTHS","PFS_STATUS","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","PRIOR_DX","RACE","RADIATION_THERAPY","RAGNUM_HYPOXIA_SCORE","SAMPLE_COUNT","SAMPLE_TYPE","SEX","SOMATIC_STATUS","SUBTYPE","TBL_SCORE","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","TISSUE_SOURCE_SITE","TISSUE_SOURCE_SITE_CODE","TMB_NONSYNONYMOUS","TUMOR_TISSUE_SITE","TUMOR_TYPE","WEIGHT","WINTER_HYPOXIA_SCORE"],"molecularProfileIds":["ov_tcga_pan_can_atlas_2018_gistic","ov_tcga_pan_can_atlas_2018_log2CNA","ov_tcga_pan_can_atlas_2018_mutations","ov_tcga_pan_can_atlas_2018_protein_quantification","ov_tcga_pan_can_atlas_2018_protein_quantification_zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_Zscores","ov_tcga_pan_can_atlas_2018_rppa","ov_tcga_pan_can_atlas_2018_rppa_Zscores","ov_tcga_pan_can_atlas_2018_structural_variants"],"genericAssayProfiles":["ov_tcga_pan_can_atlas_2018_armlevel_cna","ov_tcga_pan_can_atlas_2018_genetic_ancestry","ov_tcga_pan_can_atlas_2018_methylation_hm27_hm450_merge","ov_tcga_pan_can_atlas_2018_methylation_hm450","ov_tcga_pan_can_atlas_2018_phosphoprotein_quantification"],"heatmapProfileIds":["ov_tcga_pan_can_atlas_2018_protein_quantification_zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_Zscores","ov_tcga_pan_can_atlas_2018_rppa_Zscores"],"availableComparisonTabs":["overlap","clinical","survival","alterations","mutations","mrna","protein","generic_assay_armlevel_cna","generic_assay_genetic_ancestry","generic_assay_methylation","generic_assay_phosphosite_quantification"]}}]}}

▶ navigate_to_results_view
{
 "studyIds": [
  "ov_tcga_pan_can_atlas_2018"
 ],
 "genes": [
  "EGFR"
 ],
 "tab": "plots",
 "profileFilter": "log2CNA,rna_seq_v2_mrna",
 "plotsHorzSelection": {
  "dataType": "copy_number_alteration",
  "selectedGeneOption": "EGFR",
  "selectedDataSourceOption": "ov_tcga_pan_can_atlas_2018_log2CNA"
 },
 "plotsVertSelection": {
  "dataType": "mrna_expression",
  "selectedGeneOption": "EGFR",
  "selectedDataSourceOption": "ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna",
  "logScale": "true"
 }
}

◀ result
{"success":true,"message":"Navigating to https://www.cbioportal.org/results/plots?cancer_study_list=ov_tcga_pan_can_atlas_2018&gene_list=EGFR&case_set_id=ov_tcga_pan_can_atlas_2018_all&profileFilter=log2CNA%2Crna_seq_v2_mrna&plots_horz_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22copy_number_alteration%22%2C%22selectedDataSourceOption%22%3A%22ov_tcga_pan_can_atlas_2018_log2CNA%22%7D&plots_vert_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22mrna_expression%22%2C%22selectedDataSourceOption%22%3A%22ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna%22%2C%22logScale%22%3A%22true%22%7D","url":"https://www.cbioportal.org/results/plots?cancer_study_list=ov_tcga_pan_can_atlas_2018&gene_list=EGFR&case_set_id=ov_tcga_pan_can_atlas_2018_all&profileFilter=log2CNA%2Crna_seq_v2_mrna&plots_horz_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22copy_number_alteration%22%2C%22selectedDataSourceOption%22%3A%22ov_tcga_pan_can_atlas_2018_log2CNA%22%7D&plots_vert_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22mrna_expression%22%2C%22selectedDataSourceOption%22%3A%22ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna%22%2C%22logScale%22%3A%22true%22%7D","data":{"studyIds":["ov_tcga_pan_can_atlas_2018"],"studies":[{"studyId":"ov_tcga_pan_can_atlas_2018","name":"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)","sampleCount":585}],"genes":["EGFR"],"caseSetId":"ov_tcga_pan_can_atlas_2018_all","pageDescription":"Scatter/box plots: EGFR mrna_expression (y-axis) by EGFR copy_number_alteration (x-axis)."}}

═ answer (success)
## EGFR Copy Number vs. mRNA Expression — Ovarian Cancer (TCGA, PanCancer Atlas)

In the **Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)** cohort (`ov_tcga_pan_can_atlas_2018`, 585 samples), among the **295 samples** with both continuous copy-number and RNA-seq data profiled for EGFR:

| Comparison | Correlation coefficient | n |
|---|---|---|
| Log2 copy-number ratio vs. log2(RSEM+1) mRNA expression | Pearson r = **0.342** | 295 |
| Log2 copy-number ratio vs. mRNA expression (rank-based) | Spearman ρ = **0.364** | 295 |
| Discrete GISTIC CNA call vs. mRNA expression (rank-based) | Spearman ρ = **0.411** | 295 |

This is a **moderate positive correlation** — samples with EGFR copy-number gain tend to show higher EGFR mRNA expression, consistent with dosage-driven transcription, but copy number alone explains only a modest fraction of expression variance (r² ≈ 0.12).

**Caveats:**
- The denominator (295) reflects samples with *both* assay types profiled — not all 585 study samples have copy-number data on this legacy CNA profile.
- These figures come directly from database computation, not a statistical package; treat them as descriptive correlation values rather than a formally tested hypothesis (no p-value is reported here).

You can inspect the underlying scatter plot, including per-sample points and an option to overlay a regression line/Pearson or Spearman stat directly in the portal:

[EGFR Copy Number vs. mRNA Expression — Plots View](https://www.cbioportal.org/results/plots?cancer_study_list=ov_tcga_pan_can_atlas_2018&gene_list=EGFR&case_set_id=ov_tcga_pan_can_atlas_2018_all&profileFilter=log2CNA%2Crna_seq_v2_mrna&plots_horz_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22copy_number_alteration%22%2C%22selectedDataSourceOption%22%3A%22ov_tcga_pan_can_atlas_2018_log2CNA%22%7D&plots_vert_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22mrna_expression%22%2C%22selectedDataSourceOption%22%3A%22ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna%22%2C%22logScale%22%3A%22true%22%7D)

The portal will compute and display its own Pearson/Spearman statistic on that plot, which you can toggle between linear/discrete CNA axis modes.